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Background:  There is growing awareness that different terminal diseases translate into 
different family caregiver experiences, and the palliative and supportive care needs of 
these families are both similar and unique.  Family members caring for people with motor 
neurone disease (MND) may experience exceptional strain due to the usually rapid and 
progressive nature of this terminal illness.   
Aim:  The purpose of this review is to synthesize contemporary research and provide 
a comprehensive summary of findings relevant to MND family caregivers, as well as 
highlight some of the suggested interventions to alleviate burden and improve quality of life 
for this group.  
Design:  We conducted a comprehensive review of empirical research on family 
caregiving for people with MND in peer-reviewed journals published in English, January 
2000 - April 2011.  Fifty-nine studies met the inclusion criteria. 
Results:  This comprehensive literature review was consistent with previous research 
documenting the substantial burden and distress experienced by MND family caregivers, 
and revealed important points in the trajectory of care that have the potential for negative 
effects.  The diagnosis experience, assisted ventilation, cognitive changes, and end of life 
decision making, create challenges within a short time. This review has also implicated 
the need for improvements in access to palliative care services and highlighted the 
absence of interventions to improve care. 
Conclusions: Caregiver burden and quality of life studies on MND family caregivers have 
so far dominated the research landscape .The focus needs to be on developing 
interventions that provide direct practical and psychosocial supports for MND caregivers. 
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A 10-YEAR LITERATURE REVIEW OF FAMILY CAREGIVING FOR 
MOTOR NEURONE DISEASE: MOVING FROM CAREGIVER BURDEN 
STUDIES TO PALLIATIVE CARE INTERVENTIONS 
   
INTRODUCTION  
Motor neurone disease (MND) refers to four disorders involving the degeneration of 
motor neurones controlling voluntary muscles that enable people to move, speak, breathe and 
swallow.  Amyotrophic lateral sclerosis (ALS) is the most common type and the two terms 
MND and ALS are used synonymously and vary by country.  The person with MND endures 
progressive paralysis, and death is most often caused by respiratory failure (1). The cause is 
unknown and there is no known cure (2). The median life expectancy is two to four years 
after diagnosis (3). While presenting symptoms and disease course vary, MND is always 
progressive with no periods of remission (4).  Symptoms include muscle weakness and 
atrophy, difficulty breathing and swallowing, speech problems, emotional lability, and pain 
(5).  The supportive and palliative care goals for people with MND include maintaining 
physical function and independence for as long as possible, managing pain and other physical 
symptoms, facilitating communication about end of life issues, and providing psychosocial 
support for the person and their family throughout the disease (5-7).  Though MND is 
relatively uncommon, with a prevalence of 7 in 100,000 (8) the associated direct (e.g. health 
care, expensive equipment) and indirect (lost productivity and income) costs and intangible 
losses (independence, quality of life) all contribute to the high cost of this illness to society 
(9). 
In general, end-of-life caregiving by families is demanding and associated with 
morbidity and mortality (10-12). Family members caring for those with MND may 
experience exceptional strain due to the usually rapid and progressive nature of this terminal 
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illness, coupled with the particularly debilitating effects of MND (13).  Awareness has been 
mounting about the specific difficulties relating to caring for a person with MND and the 
palliative and supportive care needs of these families (14, 15).  An understanding of the 
disease trajectory of MND (16), the common challenges faced by MND family caregivers, 
and how the available support to these family caregivers translates into different caregiver 
experiences (17) are all highlighting how providing family care for a person with MND is 
both similar to and unique from family caregiving in other terminal disease populations. 
PURPOSE 
The purpose of this review is to synthesize contemporary research and provide a 
comprehensive and up to date summary of findings relevant to family caregivers of people 
with MND concerning their experiences, burden and quality of life issues, and service needs. 
Moreover, this review highlights the interventions suggested by the research to alleviate 
burden and improve the quality of life of MND family caregivers.  
Published research from 2000 through April 2011 on family caregiving for people 
with MND is reviewed. Only one previous review has been published in this area by 
Mockford, et al, for the period 1994-2004, encompassing 30 studies (18).  The main findings 
of this review indicated that the mental and physical health of caregivers were at risk without 
improved access to resources and support.  Two themes emerged from the review: 1) the 
impacts on MND carers and 2) service needs and provision.   
Since 2004, an additional 43 studies have been published in peer-reviewed journals on 
a broad range of issues confronting family caregivers of people with MND.  We update 
Mockford’s review with the most current research on MND family caregiver impacts and 
service needs.  Sixteen studies are common to both reviews.   In addition, our review adds a 
third dimension: the unique challenges faced during MND family caregiving as a result of the 
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disease trajectory.  These challenges encompass the impact of the diagnosis experience on 
MND family caregivers, the ongoing difficulties in obtaining adequate information and 
access to services from health care providers, the toll on family carers when cognitive and 
neurobehavioral changes associated with MND are encountered, the considerable burden 
associated with the decision and transition to assisted ventilation, caregiving in the last 
months of life, and how all of these factors impact on bereavement.  
METHODS 
We conducted a comprehensive review of empirical research on family caregiving for 
people with MND published between January 2000 and April 2011.  This 10-year period was 
examined in order to assess the most recent contributions to this field of research and to 
examine whether there were identifiable and distinct aspects of MND family caregiving. 
Inclusion/exclusion criteria 
The population addressed is family caregivers who provide care for someone 
diagnosed with MND, although a definition of “family caregiving” was not applied in the 
articles.  Therefore, we included all articles in which family members or partners were 
involved in the direct or indirect care of someone with MND. We excluded studies that 
focused on family carers’ proxy accounts of patient care or symptoms, as well as those 
documenting instrument development and validation.  Only empirical, peer-reviewed journal 
articles published in English were included.  Qualitative, quantitative and mixed methods 
studies were considered.  Exclusions were not made on the basis of assessments of the rigour, 
validity, and reliability of studies and their findings, as would be typical in a systematic 
review. Given that most studies on caregiving at the end of life fell into evidence levels III 
(non-randomised comparative  studies)  and the limitations of the study designs, it was 
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difficult to grade using traditional taxonomies for levels of evidence for systematic reviews 
(19). 
Search Strategy 
The databases searched were Global Health, Medline, ProQuest Health and Medical 
Complete, PsychINFO, Science Direct, CINAHL (EBSCO), and Current Contents Connect.  
We used any combination of the following search terms: palliative care, supportive care, end 
of life care AND carer(s), caregiver(s), family caregiver(s), family carer(s), AND motor 
neuron(e) disease, amyotrophic lateral sclerosis, neurodegenerative disease.  To augment the 
computer-based search, a manual search of the reference lists of all retrieved articles was 
conducted. 
RESULTS 
The electronic search identified more 1625 articles in all databases.  After excluding 
duplicates and studies where caregiving for those with MND was not a central or partial 
focus,  216 abstracts were identified for review.  Of these, a total of 59 studies met the 
inclusion criteria (Figure 1).  A summary of the main features of the studies reviewed, 
including locations, sample size, methodology, and primary focus are presented in Table 1.  
More details on the key characteristics of the reviewed studies are presented in Table 2. 
Conceptual and Definitional Issues 
Many studies did not clearly define key concepts, such as “caregiver.” Thirty-three 
(56%) articles did not define it at all, and others used a variety of definitions such as “the 
primary caregiver or the person most or primarily involved in patient care” (12%).  The terms 
“end of life care” and “palliative /supportive care” were not defined or poorly defined in all 
the studies, making it difficult to determine the nature of the care being discussed.  While 
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most studies addressed “caregiver burden” and/or “quality of life,” few defined these terms.  
In the majority of the studies, the care setting where caregiving was being provided was also 
not stated or clearly defined making it difficult to distinguish the setting of care in many 
articles.  Close inspection of the recruitment procedure and findings suggested that people 
with MND received primarily home-based care. 
STUDIES REVIEWED 
Key findings reported in the literature are grouped into three major themes: 1) the 
unique experiences of family caregiving for someone with MND, with a focus on caregiver 
time, cognitive and neurobehavioral decline, assisted ventilation, caregiving in the last 
months of life, requests for hastened death and bereavement; 2) caregiver burden and quality 
of life issues; and 3) identified service needs.     
The unique experiences of caring for someone with MND 
A family caregiver for a person with MND quickly encounters life changes of great 
magnitude.  MND typically involves a rapid functional decline with a short disease trajectory; 
50% die within 3 years of symptom onset (20).  During this time, people with MND lose the 
ability to move, eat, breathe, and speak, necessitating transitions to wheelchairs and the use of 
other mobility aids, Percutaneous Enteral Gastronomy (PEG) feeding, the use of assistive 
communication devices, and the use of assisted breathing devices( Non-Invasive Positive-
Pressure Ventilation [NIPPV] and/or tracheostomy and Long Term Mechanical Ventilation 
[LTMV]) (21).  Thus, caregivers face daily changes, as well as long term adjustments (22).   
Stresses and challenges include: dealing with swallowing and eating difficulties (23); worries 
about the illness progression and the well-being of family (23, 24);  changes in family roles 
(22, 25); loss of a sexual relationship between spouse caregivers and people with MND (21, 
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26); loss of a reciprocal relationship with spouse caregivers (27); and being blamed by other 
family members for inadequate care (28). 
Caregiver time 
Over time, people with MND require increasing levels of assistance with nearly all 
aspects of daily living (13).  In an Italian study, it was reported that caregiver time for people 
with MND is highly related to overall disability and ranged from 5 hours per day for those 
with mild disability to 15 hours per day for those with severe impairment.  Losing the ability 
to walk had the greatest impact on caregiving time, while the need for enteral nutrition or 
assisted ventilation had marginal impact.  A progressive increase was observed in time spent 
on toileting, bathing, dressing, administering medications, and feeding, corresponding with  
level of disability (29). 
Cognitive and neurobehavioral decline 
Up to fifty percent of people with MND will develop neurobehavioral symptoms, 
from a subtle cognitive decline to serious impairment (30).  Apathy, executive dysfunction 
and disinhibition are the most common neurobehavioral symptoms of patients reported by 
caregivers (30, 31).  In about 15% of cases, people with MND will develop frontotemporal 
dementia which presents additional challenging neurobehavioral symptoms for family 
caregivers including irritability, impulsivity, loss of insight, self-centeredness and lack of 
empathy, aggression, food cravings, and obsessions and/or compulsive behaviors (30).  A 
German study found that burden is markedly higher in MND caregivers who report 
encountering “problem-behavior” (32).  Cognitive changes have a profound impact on 
caregivers, sharply increasing depression and burden and negatively impacting their quality 




Respiratory muscle weakness increases over time and people with MND begin to 
experience hypoventilation (33).  Five studies looked at how the symptom of breathlessness 
and subsequent assisted ventilation, if chosen, affected caregiver burden and quality of life.  
A study in the U.K. found caregivers generally feel helpless when confronted with 
breathlessness and ill-prepared to cope, causing anxiety, depression, and distress (34).  Both 
NIPPV and LTMV increase survival time for people with MND, leading to an extended 
period of caregiving (33, 35).  Studies in the U.S., Japan and Germany point to the particular 
role of LTMV in caregiver burden, stress and distress (21, 35, 36).   Burden was reported in 
relation to how LTMV caregivers often become acutely aware of their responsibility for the 
survival of their family member, from managing the tracheostomy and suctioning the airway, 
to managing equipment and arranging back-up power sources.  Because of these 
responsibilities, family caregivers of people on LTMV often give up all but essential outside 
activities and relinquish their personal lives (35, 36).    
End-of-life caregiving and requests for hastened death 
 At the end of life, as family caregivers lose the ability to interact with their loved 
ones, they begin to struggle with meaning and feel powerless (36).  Pagnini (37) found that, 
as people with MND lost function, their caregivers exhibited increased symptoms of somatic 
depression such as reduced quality of sleep and appetite.  There is some data to indicate that 
people with MND and their family caregivers do not always hold the same attitudes or beliefs 
about care (38), or agree about treatment course or end-of-life decision making (39).  People 
with MND may refuse life-sustaining treatments, such as tracheostomy or assisted ventilation 
(21), or may have interest in hastening death, all of which can cause distress for their 




MND continues to affect families after death, despite the end to caregiving.  In 
bereavement, MND caregivers experienced lasting emotional impacts, including sadness, 
fear, frustration, hatred and anger, depression, and, for some, hopelessness (41).   An 
Australian study  demonstrated that MND family caregivers are at risk of prolonged grief 
(42). While there is a strong recognition for the value of grief and bereavement support,  this 
support is often inadequate (41, 42).  In a 2001 Canadian study, 37% of caregivers were 
coping poorly or very poorly, sometimes years after death (28).  Martin and Turnbull (28) 
also found lasting financial hardship reported by 22% to 26% of bereaved families.  
Caregiver Burden and Quality of Life  
MND caregiver burden and quality of life (QOL) were explored within 40 articles in 
this review, all of  which documented the considerable burden attached to care provision (43, 
44).  Burden was most frequently reported in the domain of time-dependence, reflecting the 
lack of time for oneself as the main reason for caregiver strain (13, 15, 37, 45).  Generally 
negative outcomes on MND caregiver QOL were documented (44, 46-48).  Caregiver QOL 
appears unrelated to the severity of MND, patient QOL, or the level of care (40, 49, 50).  In a 
longitudinal study, Gauthier (15) found caregiver emotional burden and total burden 
increased over time, but QOL remained stable. 
Mitigating factors associated with caregiver burden and quality of life 
Caregiver burden increases as patient function declines (15, 37, 51), but caregiver 
QOL appears dependent on factors other than the physical decline of the care recipient (49) 
such as religiousness (52).  Caregiver burden may be mitigated through positive social 
support  (26, 37, 49, 53, 54),   Studies in the U.K. and Australia identified how high 
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satisfaction with social support helped mitigate potentially negative effects of MND on 
quality of life and the marital relationship between spouses and caregivers (26, 53).  Several 
studies (22, 38, 55, 56) indicated that family caregivers need a confidant to mitigate isolation.  
Yet MND caregivers, particularly those providing prolonged care, face challenges seeking 
and maintaining social support, interaction, and help from informal networks (13, 54, 57).  
MND caregivers tend to have reduced social contacts, social network size and quality due to 
caregiving (39, 54, 58), which may contribute to social isolation and perceived burden (54).  
There are indications that female MND caregivers may experience greater burden than men 
(13, 31, 32, 53, 59).   
Caregiver physical concerns 
MND caregivers commonly expressed concerns  about their own health (37). The 
most reported physical health concerns among MND caregivers include physical exhaustion 
or fatigue (15, 27, 40, 57, 60), followed by insomnia and interrupted sleep (46, 57, 61, 62).  
MND caregivers may have self-care difficulties due to a lack of time for their own needs 
(60). 
Depression and Anxiety 
The most commonly documented mental and psychological health symptoms and 
issues among MND caregivers included depression (13, 15, 39-41, 45, 46, 60, 63, 64); 
psychological distress (15, 40, 50, 57, 60); and anxiety (27, 41, 46, 57, 62, 63, 65).  
Depression rates may be influenced by culture or ethnicity.  One study using a Japanese 
sample of MND caregivers reported extremely high rates of depression (61%) (45); in 
contrast, two studies of American MND caregivers report low rates (19% and 23%) even 
when patients were severely disabled (40, 60).   
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Depression tends to increase over time (15, 51) in connection with multiple losses and 
changes faced by MND family caregivers (27), as well as caregiving intensity and 
supervision time (45); perceptions of the patient as unsupportive or critical (60); household 
income (45); burden (15); and the use of avoidance coping strategies rather than problem-
solving (60).  Caregiver depression may be related to patient depression (13, 40).  Rabkin et 
al. (60) indicated that psychological distress, rather than psychopathology (e.g. clinical 
depression), was more reflective of the circumstances of caregivers of late-stage MND 
patients.   
Only one study conducted in Italy formally assessed anxiety in MND caregivers, 
reporting prevalence rates from 71 to79% (65).  MND caregiver anxiety may be associated 
with the levels of the patient's disability (38, 44);  or may arise from being unable to make 
plans on a daily basis, due to the uncertainty of disease trajectory (27).   
Service needs among caregivers of people with MND  
Information and communication 
Communication difficulties  with health professionals over  obtaining adequate 
information about diagnosis, health status, prognosis, trajectory, and treatment options were 
identified in several studies
 
(22, 25, 38, 55, 62, 66-68).  Caregivers in Australia and the U.K. 
were distressed when it took a long time to obtain a diagnosis, and when medical specialists 
lacked empathy and communication skills (68, 69).  Diagnostic experiences can be 
particularly stressful for caregivers (70).  However, studies suggested that communication at 
this time could be improved (38, 42, 55, 71).  McClusky et al., (71) found the average time 
spent imparting the diagnosis in a U.S. study was 30 minutes, and while 65% of doctors 
identified MND as a terminal disease, only 11% discussed palliative care options. Four  
qualitative studies describe the poor experiences of patients and family caregivers at the time 
 11 
  
of diagnosis, including receiving the news over the phone in a short, business-like phone call 
with minimal information (19, 55).  In cases where diagnosis is relayed poorly, there can be 
considerable emotional consequences for family caregivers that may linger into bereavement 
(42).  
Even when caregivers were largely satisfied with how the diagnosis was 
communicated, they also expressed barriers to having their information needs met, and 
presented a need from the beginning for more general information about MND prognosis, as 
well as information about current MND research, therapies that slow down MND 
progression, potential cures, MND outcomes, and information on ventilation (22, 36, 62, 66). 
Access to and information about resources and equipment was another identified need (25, 
38, 46, 62), as is help with family communication (46, 47). 
Identified needs and service gaps in palliative/supportive care 
Assistance for caregivers with several aspects of patient care needs and symptom 
management were indicated in several Australian studies, as well as related needs for home 
support, home care and respite, and financial assistance (28, 46, 47, 69).  Access to experts 
from a variety of agencies (62) and access to community rehabilitation are identified needs 
(46, 47), but respite care was singled out as the most important service that would enable 
caregivers to continue providing care (72). 
Other needs include direct help or guidance with practical/medical aspects of care 
(i.e., symptom and medication management, technological tasks) (25); personal care needs 
(dressing, washing and showering) (25, 46, 72); household and instrumental tasks (25, 72).  
Persistent patient breathlessness at the end of life has been identified as one of the most 
difficult symptoms for caregivers (including MND caregivers) to deal with (34).  
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As MND has an identifiable terminal stage from the start of diagnosis, a palliative 
care approach for MND has been emphasized (7, 46, 47).  Palliative care approaches, 
including symptom management, supportive services, counselling and family care plans, are 
relevant for MND. They can also help prepare MND caregivers for the physical and 
emotional decline in people with MND (62).  Nonetheless, there is evidence that when 
palliative care is available, both people with MND and their caregivers find it difficult to 
access these services (20, 73). In a Western Australian study, it was found that less than 10% 
of people who died of non-malignant diseases had accessed specialist palliative care services, 
compared with 66% of people who died of cancer (74). Thus, there appears to be a need for 
increased understanding and application of a palliative care approach to care delivery for 
those with MND and their caregivers.  
DISCUSSION AND CONCLUSIONS 
This review summarized the literature between 2000 and early 2011. While caregiver 
burden and quality of life studies have dominated the research and documented the 
substantial distress experienced by MND family caregivers, more studies are now emerging 
that provide guidance about how to provide optimal palliative and supportive care to people 
with MND and their family caregivers.  Important milestones in care have been identified, 
such as diagnosis, accessing information and services, cognitive and behavioral changes that 
can occur in MND, the decision to receive assisted ventilation, end of life decision-making, 
and bereavement.  However, the development and testing of interventions focused on 
providing direct supports and outcomes for MND caregivers appears to be lacking. 
Limitations 
Many of the study methodologies have limitations that weaken the validity of the 
findings, including: small sample sizes and non-random samples. Most studies of 
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psychological distress in MND caregivers were further limited by non-standardised 
instruments and caregiver self-reports (rather than systematic clinical approaches).  Female 
caregivers are overrepresented in the studies.  Caregivers at the end of life were 
underrepresented as people with MND who are more severely impaired are harder to recruit 
and their caregivers are less likely to participate because they are coping with increased 
disease burden.  Also, due to ethical reasons, some studies excluded caregivers who were 
caring for patients at the last stage of MND (e.g. 55). This limitation may also arise from 
gate-keeping, where health care practitioners may seek to exclude patients they see as 
vulnerable from participating in research (46, 47).  
Limitations of this review include the focus on studies published in English; relevant 
studies in other languages may exist. A lack of generalisation to other ethnic/cultural groups 
and to those from non-English-speaking backgrounds is also indicated.  Additionally, the 
studies were not assessed for the quality of the research design and we did not fully consider 
the psychometric properties of various rating scales and instruments used by the researchers.   
Except for one large-scale national study (46, 47) and one European study (44), most studies 
were local, single-site research, involving mostly non-representative samples with a potential 
for bias.  Given the diverse terminologies, differing objectives and a range of measures used 
in MND caregiving studies, there are considerable challenges in attempts to analyse and 
compare important constructs (such as caregiver burden, psychological distress, QOL, etc.) 
among the studies. Nevertheless, there is enough consistency in the findings to explore the 
implications for service provision and inform future research.  
Implications for service provision 
While studies have continued to document evidence of burden and distress in MND 
family caregivers, this evidence is rarely translated into improvements in practice through the 
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development of interventions.  Six especially challenging points in the caregiving trajectory 
emerged from the recent literature: the diagnosis, obtaining information and access to health 
care services, the decision and transition to assisted ventilation, encountering neurobehavioral 
changes in the patient, caregiving and decision making in the last months of life, and 
bereavement.  The types of interventions suggested in the literature reviewed to support 
MND family caregivers can be grouped into three broad and overlapping areas: 1) providing 
direct support to family caregivers of people with MND to meet their practical and emotional  
needs; 2) providing education and training to health care providers in order that they may 
better meet the emotional and practical needs of people with MND and their family 
caregivers; and 3) providing interventions which support the existential and spiritual concerns 
of both people with MND and family caregivers.  To date, there are no intervention studies 
that assessed direct supports and outcomes for MND caregivers.  However, certain 
recommendations for future interventions could be gleaned from many of the studies.   
Providing supportive services and addressing caregivers’ support networks 
As there is a clear correlation between quality of life and the amount of support 
experienced by MND caregivers (37), interventions that bolster support  were the most 
commonly implicated by the studies reviewed.  This included interventions in the caregiving 
situation through: providing paid assistance  for home help services(72); helping caregivers 
both socially connect with and mobilize their informal networks (32, 58); connect with 
community support groups (13); providing direct psychological support (60); and targeted 
delivery of psycho-educational programs (50, 63, 64). 
The quality of life of both people with MND and their family caregivers appears 
primarily dependent on relationship and psychosocial issues, and the wellbeing of both 
parties is linked.  Counselling interventions can support the patient and caregiver relationship 
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(24).  At least two studies indicated that spouse caregivers of people with MND are 
concerned with the loss of their sexual relationships, and interventions should be developed 
to address this often overlooked area (21, 26).   
Emotional support programs for both the family caregiver and person with MND are 
indicated to mitigate the diagnosis experience (68).  For caregivers who encounter 
neurobehavioral issues in care recipients, support interventions that offer problem-solving 
strategies and which provide emotional support are needed (31).  As the patient approaches 
the end-of-life, counselling interventions are needed to address distress, anxiety and somatic 
expressions of depression (37). The identification of risk factors for prolonged grief is 
indicated for the MND family caregiver, and more tailored bereavement support programs 
should be developed (42).   
Education and training for health care providers 
Several studies indicated that professional health care providers need more training  to 
improve their communication of the diagnosis to the person with MND and their family, to 
provide useful information to families after diagnosis (1, 66), and to effectively communicate 
about end of life care preferences (75).  Professional education and training programs can 
enhance the understanding of  MND by service providers (20), as well as their understanding 
of a palliative approach for people with MND, ability to promote dignity and quality of life 
and better communication with MND patients and their caregivers (76).  
Interventions supporting existential and spiritual concerns 
The development of spiritually-based interventions have been indicated by several 
studies to potentially improve MND caregiver’s quality of life (49, 50, 52, 77).  An Italian 
study  has indicated that interventions that improve existential wellbeing in people with MND 
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will also improve the psychological wellbeing of their family caregivers (37).   Dignity 
Therapy (78), which focuses on maintaining hope and a sense of meaning in the patient, may 
reduce requests for a hastened death at the end of life, indirectly reducing caregiver distress 
(79).  Dignity Therapy has also been shown to moderate the bereavement experience of 
family members, indicating another possible benefit to MND caregivers (80).   These types of 
interventions and others may be developed and evaluated for future use in MND caregivers.   
Conclusion 
Research findings have been consistent in documenting the substantial burden and 
distress experienced by MND family caregivers.  Numerous suggestions have emerged 
through the research for the development of interventions and supportive services to improve 
the psychological wellbeing and quality of life for these caregivers.  The research literature 
has also documented the need for improved access to palliative care services and made 
suggestions for interventions to improve care for both people with MND and their family 
caregivers.  Meanwhile, there appears to be a lack of research into the development of such 
interventions which will alleviate the burden on MND family carers and improve care for 
patients.   
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